ClassID:

110899

C12N2760/18134 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae; Avulavirus, e.g. Newcastle disease virus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260061047
2026-03-05

Newcastle Disease Virus with Improved Heat Resistance, and Newcastle Disease Virus Vaccine Comprising Same

#2
20250333766
2025-10-30

RECOMBINANT HVT VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF

#3
20250295753
2025-09-25

Larygotracheitis Virus (LT) Vector Vaccines for use with Avian Respiratory Pathogens

#4
20250295752
2025-09-25

VACCINE AGAINST INFECTIOUS BRONCHITIS

#5
20250228929
2025-07-17

RECOMBINANT NEWCASTLE DISEASE VIRUSES AND IMMUNOGENIC COMPOSITIONS FOR USE IN IMMUNIZING AGAINST SARS-COV-2 OMICRON VARIANT

#6
20250161435
2025-05-22

MULTIVALENT KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS-LIKE PARTICLES AND USES THEREOF

#7
20250073331
2025-03-06

USE OF CODON DEOPTIMISATION AND OPTIMISATION TO PRODUCE A LARYNGOTRACHEITIS VIRUS-ATTENUATED VACCINE

#8
20240374702
2024-11-14

RECOMBINANT HERPESVIRUS OF TURKEY VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF

#9
20240252624
2024-08-01

RECOMBINANT HVT VECTORS EXPRESSING INFLUENZA HEMAGGLUTININ AND IMMUNOGENIC COMPOSITIONS, AND PRODUCTION AND USES THEREOF

#10
20240199705
2024-06-20

CHIMERIC NEWCASTLE DISEASE VIRUS EXPRESSING APMV HN AND F PROTEINS

#11
20240181477
2024-06-06

EXTENDED-RANGE SPRAY APPLICATOR

#12
20240082390
2024-03-14

MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES

#13
20240082386
2024-03-14

METHODS FOR IMMUNIZING PRE-IMMUNE SUBJECTS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)

#14
20240042037
2024-02-08

REDUCED FOAMING VACCINE COMPOSITIONS

#15
20230175017
2023-06-08

RECOMBINANT HVT VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF

#16
20230147673
2023-05-11

RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF

#17
20230031097
2023-02-02

MULTIVALENT HVT VECTOR VACCINE

#18
20220409718
2022-12-29

Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof

#19
20220396809
2022-12-15

ENGINEERED NEWCASTLE DISEASE VIRUS VECTOR AND USES THEREOF

#20
20220347295
2022-11-03

Vaccine delivery method

#21
20220241421
2022-08-04

REDUCED FOAMING VACCINE COMPOSITIONS

#22
20220233680
2022-07-28

Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)

#23
20220175911
2022-06-09

Vaccine against infectious bronchitis

#24
20220143174
2022-05-12

Multivalent Kaposi sarcoma-associated herpesvirus-like particles and uses thereof

#25
20210401973
2021-12-30

Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species

#26
20210338802
2021-11-04

Composite multi-epitope expression cassette, a recombinant virus composed thereof and application thereof

#27
20210275662
2021-09-09

Method for rescuing and producing a virus in avian cells

#28
20210236536
2021-08-05

USE OF BETA-GLUCAN EXTRACT IN IMMUNOPOTENTIATION OF AN AVIAN ANIMAL

#29
20210197217
2021-07-01

Extended-range spray applicator

#30
20210196811
2021-07-01

Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof

#31
20210015916
2021-01-21

Vaccine delivery method

#32
20210010033
2021-01-14

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof

#33
20200215183
2020-07-09

Production of flu vaccine in

#34
20200188519
2020-06-18

REDUCED FOAMING VACCINE COMPOSITIONS

#35
20200108137
2020-04-09

Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species

#36
20200038505
2020-02-06

Virus-like particle compositions and vaccines against epstein-barr virus infection and disease

#37
20200038503
2020-02-06

Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)

#38
20190249196
2019-08-15

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof

#39
20190240315
2019-08-08

Vaccine against infectious bronchitis

#40
20190151451
2019-05-23

Methods of making solid vaccine compositions having reduced foaming

#41
20190000978
2019-01-03

Reduced foaming vaccine compositions

#42
20180369362
2018-12-27

INFECTIOUS BRONCHITIS VIRUS VACCINE USING NEWCASTLE DISEASE VIRAL VECTOR

#43
20180353595
2018-12-13

Vaccine composition and preparation method and use thereof

#44
20180256707
2018-09-13

Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species

#45
20180256706
2018-09-13

Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species

#46
20180230439
2018-08-16

Altered avian virus for in-ovo inoculation and methods of use thereof

#47
20180214538
2018-08-02

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

#48
20180163230
2018-06-14

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof

#49
20180135026
2018-05-17

DUCK EMBRYONIC DERIVED STEM CELL LINES FOR THE PRODUCTION OF VIRAL VACCINES

#50
20180078634
2018-03-22

Virus-like particle compositions and vaccines against Epstein-Barr virus infection and disease

#51
20180078590
2018-03-22

In ovo delivery of probiotic cultures

#52
20180016559
2018-01-18

Recombinant MDV1 and the uses thereof

#53
20170348413
2017-12-07

Influenza H5 vaccines

#54
20170306353
2017-10-26

HVT-vectored ND-IBD vaccine

#55
20170224807
2017-08-10

Newcastle disease virus vectored avian vaccines

#56
20170202958
2017-07-20

VACCINE DELIVERY METHOD

#57
20170106079
2017-04-20

Oncolytic heterologous recombinant newcastle disease virus, preparation method and application thereof

#58
20170095516
2017-04-06

In ovo delivery of probiotic cultures

#59
20170072046
2017-03-16

Immunogenic composition

#60
20170049880
2017-02-23

Infectious laryngotracheitis virus (ILTV) vaccine using recombinant newcastle disease virus vector

#61
20170037379
2017-02-09

Chimeric viruses presenting non-native surface proteins and uses thereof

#62
20170029470
2017-02-02

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

#63
20160317655
2016-11-03

Traditional chinese medicine mulberry leaves polysaccharide and eucommia polysaccharide immunostimulant and application thereof

#64
20160279227
2016-09-29

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

#65
20160257940
2016-09-08

Method of making a virus using duck embryonic derived stem cell lines

#66
20160256554
2016-09-08

Reduced foaming vaccine compositions

#67
20160229896
2016-08-11

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

#68
20160220657
2016-08-04

Recombinant Marek's disease viruses and uses thereof

#69
20160158347
2016-06-09

Acceleration of vector virus induced immune response in avians

#70
20160015801
2016-01-21

Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof

#71
20150344528
2015-12-03

Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens

#72
20150283225
2015-10-08

Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof

#73
20150157704
2015-06-11

Newcastle disease virus vectored herpesvirus vaccines

#74
20150118250
2015-04-30

Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species

#75
20150056245
2015-02-26

RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE

#76
20150037355
2015-02-05

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

#77
20140294893
2014-10-02

Recombinant nonpathogenic MDV vector providing multivalent immunity

#78
20140234358
2014-08-21

Newcastle disease virus vectored avian vaccines

#79
20140205633
2014-07-24

Immunostimulatory oligodeoxynucleotides

#80
20140199343
2014-07-17

Recombinant vaccine against PRRS in a viral vector

#81
20140170185
2014-06-19

Emulsion containing a non-live medicinal substance

#82
20140154741
2014-06-05

Generation of duck cell lines

#83
20140154285
2014-06-05

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

#84
20140147465
2014-05-29

Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof

#85
20140147457
2014-05-29

Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof

#86
20130315956
2013-11-28

Newcastle disease virus and the use thereof as a vaccine

#87
20130101619
2013-04-25

Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens

#88
20130034578
2013-02-07

RECOMBINANT MULTIMERIC INFLUENZA PROTEINS

#89
20120321663
2012-12-20

Live vaccine for avian diseases

#90
20120276139
2012-11-01

USE OF NEWCASTLE DISEASE VIRUS-BASED VECTOR FOR INDUCING AN IMMUNE RESPONSE IN MAMMALS

#91
20120258134
2012-10-11

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

#92
20120231033
2012-09-13

INACTIVATED POULTRY VACCINE

#93
20120122185
2012-05-17

Chimeric viruses presenting non-native surface proteins and uses thereof

#94
20120121644
2012-05-17

Sticky soft gel for treating poultry

#95
20120052089
2012-03-01

Newcastle disease virus vectored herpesvirus vaccines

#96
20120021005
2012-01-26

formulation

#97
20110311578
2011-12-22

RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE

#98
20110223195
2011-09-15

COMPOSITION COMPRISING CHITOSAN FOR OCULAR ADMINISTRATION OF VACCINE(S) TO AVIANS

#99
20110162115
2011-06-30

Recombinant NDV antigen and uses thereof

#100
20110150940
2011-06-23

DRY POWDER COMPOSITIONS AND SYSTEMS FOR POULTRY VACCINATION

#101
20110110975
2011-05-12

INACTIVATED VIRUS COMPOSITIONS AND METHODS OF PREPARING SUCH COMPOSITIONS

#102
20110097355
2011-04-28

Virus-like particles as vaccines for paramyxovirus

#103
20110081374
2011-04-07

Recombinant avian paramyxovirus vaccine and method for making and using thereof

#104
20100261206
2010-10-14

Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof

#105
20100260795
2010-10-14

Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals

#106
20100255029
2010-10-07

Newcastle disease virus vectored avian vaccines

#107
20100233785
2010-09-16

NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES

#108
20100183664
2010-07-22

Attenuated recombinant newcastle disease virus and vaccine containing the same

#109
20100158942
2010-06-24

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

#110
20100143403
2010-06-10

METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY

#111
20100136049
2010-06-03

METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY

#112
20100062489
2010-03-11

DUCK EMBRYONIC DERIVED STEM CELL LINES FOR THE PRODUCTION OF VIRAL VACCINES

#113
20100047329
2010-02-25

Novel Vaccination Carrier

#114
20100009449
2010-01-14

Preparation of vaccine master cell lines using recombinant plant suspension cultures

#115
20100008948
2010-01-14

RECOMBINANT HERPESVIRUS USEFUL IN VACCINE PRODUCTION

#116
20100008945
2010-01-14

Recombinant Newcastle Disease Virus Expressing H5 Hemagglutinin of Avian Influenza Virus

#117
20100003288
2010-01-07

CpG DNA adjuvant in avian vaccines

#118
20100003279
2010-01-07

VACCINE FOR IN OVO INOCULATION

#119
20090280144
2009-11-12

Recombinant newcastle disease virus RNA expression systems and vaccines

#120
20090263420
2009-10-22

Virus-like particles as vaccines for paramyxovirus

#121
20090258035
2009-10-15

AVIAN VIRUS VACCINES AND USES THEREOF

#122
20090220539
2009-09-03

Recombinant mononegaviral virus vectors

#123
20090203114
2009-08-13

Methods for the propagation of modified influenza viruses in embryonated eggs

#124
20090068221
2009-03-12

Virus-like particles as vaccines for paramyxovirus

#125
20090053264
2009-02-26

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

#126
20090053262
2009-02-26

Combination vaccine for poultry

#127
20090041852
2009-02-12

DRY POWDER COMPOSITIONS AND SYSTEMS FOR POULTRY VACCINATION

#128
20080226682
2008-09-18

Immunoactive Compositions for Improved Oral Delivery of Vaccines and Therapeutic Agents

#129
20080112969
2008-05-15

Recombinant Herpesvirus Useful in Vaccine Production

#130
20070243212
2007-10-18

Methods and compositions for vaccination of poultry

#131
20070243199
2007-10-18

Methods and compositions for vaccination of poultry

#132
20070178120
2007-08-02

Virus-like particles as vaccines for paramyxovirus

#133
20070107086
2007-05-10

Preparation of vaccine master cell lines using recombinant plant suspension cultures

#134
20070031450
2007-02-08

Stabilizers for veterinary vaccines

#135
20060233830
2006-10-19

Vaccines

#136
20050202045
2005-09-15

Recombinant avian herpesvirus useful in vaccine production

#137
20050130127
2005-06-16

Coronavirus-like particles comprising functionally deleted genomes

#138
20050069561
2005-03-31

Escape mutants of newcastle disease virus as marker vaccines

#139
20050054074
2005-03-10

Methods and interferon deficient substrates for the propagation of viruses

#140
18938932
2025-11-18

3 (MDV-2), a viral vector against different avian pathogens: a new vaccination strategy in the poultry industry

#141
17354470
2021-11-23

Vaccine composition for preventing human infection of SARS coronavirus and alleviating infection symptoms